Related Experiment Video
Updated: Feb 7, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms
Insights
Vigabatrin (VGB) effectively treats infantile spasms in children with tuberous sclerosis (TS). A low-dose, short-term VGB protocol shows good tolerability and seizure control, minimizing risks.
Area of Science:
- Pediatric Neurology
- Epileptology
- Genetics
Background:
- Tuberous sclerosis (TS) is a genetic disorder often associated with epilepsy, particularly infantile spasms.
- Infantile spasms in TS patients can be challenging to treat and may lead to developmental delays.
- Vigabatrin (VGB) is an established anti-epileptic drug, but its use requires careful consideration of side effects.
Purpose of the Study:
- To assess the efficacy and tolerability of vigabatrin (VGB) in pediatric patients diagnosed with tuberous sclerosis (TS).
- To specifically evaluate VGB's impact on infantile spasms and tonic seizures in children with TS.
- To determine the safety profile of a modified VGB treatment protocol in this population.
Main Methods:
- A retrospective study of 17 children with TS treated at Tohoku University Hospital between April 2010 and May 2015.
- Vigabatrin (VGB) was administered at a starting dose of 30 mg/kg/day, with a maximum treatment duration of 6 months.
- Seizure types, reduction in seizure frequency, and adverse events were systematically recorded and analyzed.
Main Results:
- Vigabatrin (VGB) demonstrated positive seizure reduction, particularly in patients with infantile spasms.
- Favorable predictors for seizure reduction included infantile spasms as the seizure type, lower maximum VGB dosage, younger age at treatment initiation, and earlier treatment post-diagnosis.
- The most common adverse events were psychiatric symptoms (n=7) and electroretinogram (ERG) abnormalities (n=2), both reversible upon dose reduction.
Conclusions:
- Vigabatrin (VGB) is an effective and well-tolerated first-line treatment for infantile spasms in children with tuberous sclerosis (TS).
- The implemented "low dosage and limited period" protocol successfully improved seizure control while mitigating potential VGB-related risks.
- This approach offers a promising strategy for managing epilepsy in pediatric TS patients, balancing efficacy with safety.
Abstract:
Objective: To evaluate the effects and tolerability of vigabatrin (VGB) in children with tuberous sclerosis (TS) with infantile spasms or tonic seizures. Methods: We examined the impact of VGB on a series of 17 children with TS visiting Tohoku University Hospital in Japan during April 2010 and May 2015. To minimize potential adverse effects, VGB was given to the patients for limited 6 months with titration from 30 mg/kg/day as an initial dose. Results: Main seizure types were classified into spasms (n=10) or tonic seizures (n=7). Seizure reduction was positively associated with seizure type of infantile spasms, lower maximum dosage, younger age on VGB administration, and earlier VGB treatment after the diagnosis. Seizure type of infantile spasm was an independent favorable predictor and also associated with long-term seizure reduction. Major adverse events included psychiatric symptoms (n=7) and electroretinogram (ERG) abnormalities (n=2). All symptoms were recovered by reducing the dosage of VGB. Conclusion: VGB is effective and well tolerated as first-line treatment for TS children with infantile spasms. Our “low dosage and limited period” protocol is efficient for improving seizure control as well as minimizing the potential risks of VGB.
Related Concept Videos
Vascular Spasm
Self-Efficacy
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

